Your browser doesn't support javascript.
loading
Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children.
Tillman, Emma M; Goldman, Jennifer L.
Affiliation
  • Tillman EM; Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, USA.
  • Goldman JL; Divisions of Pediatric Infectious Diseases and Clinical Pharmacology, Department of Pediatrics, Children's Mercy Hospital and the University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO, 64108, USA. jlgoldman@cmh.edu.
Paediatr Drugs ; 23(4): 373-380, 2021 Jul.
Article in En | MEDLINE | ID: mdl-34235634
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Acute Kidney Injury / Piperacillin, Tazobactam Drug Combination / Anti-Bacterial Agents Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Paediatr Drugs Journal subject: PEDIATRIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vancomycin / Acute Kidney Injury / Piperacillin, Tazobactam Drug Combination / Anti-Bacterial Agents Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Child / Humans Language: En Journal: Paediatr Drugs Journal subject: PEDIATRIA / TERAPIA POR MEDICAMENTOS Year: 2021 Document type: Article Affiliation country: United States Country of publication: Switzerland